Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M De Jonge

Showing results (61-70 of 158) with videos related to

Pageof 16
Sort By:
Antimicrobial Agents and Chemotherapy|March 2, 2016
In Vitro Susceptibility to Ceftazidime-Avibactam of Carbapenem-Nonsusceptible Enterobacteriaceae Isolates Collected during the INFORM Global Surveillance Study (2012 to 2014)Boudewijn L M de Jonge, James A Karlowsky, Krystyna M Kazmierczak, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|June 6, 2003
Endovascular treatment of thoracic aortic pathology: feasibility and mid-term resultsB Lamme, I C D Y M de Jonge, J A Reekers, et al.
Antimicrobial Agents and Chemotherapy|May 16, 2018
<i>In Vitro</i> Activity of Ceftazidime-Avibactam against Clinical Isolates of Enterobacteriaceae and Pseudomonas aeruginosa Collected in Asia-Pacific Countries: Results from the INFORM Global Surveillance Program, 2012 to 2015James A Karlowsky, Krystyna M Kazmierczak, Samuel K Bouchillon, et al.
Antimicrobial Agents and Chemotherapy|June 21, 2017
<i>In Vitro</i> Activity of Aztreonam-Avibactam against Enterobacteriaceae and Pseudomonas aeruginosa Isolated by Clinical Laboratories in 40 Countries from 2012 to 2015James A Karlowsky, Krystyna M Kazmierczak, Boudewijn L M de Jonge, et al.
Antimicrobial Agents and Chemotherapy|January 24, 2019
<i>In Vitro</i> Activity of Ceftazidime-Avibactam against Clinical Isolates of Enterobacteriaceae and Pseudomonas aeruginosa Collected in Latin American Countries: Results from the INFORM Global Surveillance Program, 2012 to 2015James A Karlowsky, Krystyna M Kazmierczak, Samuel K Bouchillon, et al.
Journal of Affective Disorders|December 26, 2016
The role of affect in predicting depressive symptomatology in remitted recurrently depressed patientsM de Jonge, J J M Dekker, M J Kikkert, et al.
Preventive Medicine|March 4, 2024
School-based physical activity interventions: which intervention characteristics are associated with participation and retention? A meta-analysisI van der Wurff, M Kirschner, R Golsteijn, et al.
Pediatric Blood & Cancer|October 29, 2010
Vascular Endothelial Growth Factor A isoform mRNA expression in pediatric acute myeloid leukemiaR C Kruizinga, H J M de Jonge, K R Kampen, et al.
Plos One|September 19, 2025
Can you learn not to respond to irrelevant motion while making fast arm movements?Eli Brenner, Lara M de Jonge, Niels J J Tiems, et al.
Journal of Hazardous Materials|December 1, 2015
A predictive multi-linear regression model for organic micropollutants, based on a laboratory-scale column study simulating the river bank filtration processC Bertelkamp, A R D Verliefde, J Reynisson, et al.
Pageof 16

Showing results (61-70 of 158) with videos related to

Sort By:
Pageof 16
Antimicrobial Agents and Chemotherapy|March 2, 2016
In Vitro Susceptibility to Ceftazidime-Avibactam of Carbapenem-Nonsusceptible Enterobacteriaceae Isolates Collected during the INFORM Global Surveillance Study (2012 to 2014)Boudewijn L M de Jonge, James A Karlowsky, Krystyna M Kazmierczak, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|June 6, 2003
Endovascular treatment of thoracic aortic pathology: feasibility and mid-term resultsB Lamme, I C D Y M de Jonge, J A Reekers, et al.
Antimicrobial Agents and Chemotherapy|May 16, 2018
<i>In Vitro</i> Activity of Ceftazidime-Avibactam against Clinical Isolates of Enterobacteriaceae and Pseudomonas aeruginosa Collected in Asia-Pacific Countries: Results from the INFORM Global Surveillance Program, 2012 to 2015James A Karlowsky, Krystyna M Kazmierczak, Samuel K Bouchillon, et al.
Antimicrobial Agents and Chemotherapy|June 21, 2017
<i>In Vitro</i> Activity of Aztreonam-Avibactam against Enterobacteriaceae and Pseudomonas aeruginosa Isolated by Clinical Laboratories in 40 Countries from 2012 to 2015James A Karlowsky, Krystyna M Kazmierczak, Boudewijn L M de Jonge, et al.
Antimicrobial Agents and Chemotherapy|January 24, 2019
<i>In Vitro</i> Activity of Ceftazidime-Avibactam against Clinical Isolates of Enterobacteriaceae and Pseudomonas aeruginosa Collected in Latin American Countries: Results from the INFORM Global Surveillance Program, 2012 to 2015James A Karlowsky, Krystyna M Kazmierczak, Samuel K Bouchillon, et al.
Journal of Affective Disorders|December 26, 2016
The role of affect in predicting depressive symptomatology in remitted recurrently depressed patientsM de Jonge, J J M Dekker, M J Kikkert, et al.
Preventive Medicine|March 4, 2024
School-based physical activity interventions: which intervention characteristics are associated with participation and retention? A meta-analysisI van der Wurff, M Kirschner, R Golsteijn, et al.
Pediatric Blood & Cancer|October 29, 2010
Vascular Endothelial Growth Factor A isoform mRNA expression in pediatric acute myeloid leukemiaR C Kruizinga, H J M de Jonge, K R Kampen, et al.
Plos One|September 19, 2025
Can you learn not to respond to irrelevant motion while making fast arm movements?Eli Brenner, Lara M de Jonge, Niels J J Tiems, et al.
Journal of Hazardous Materials|December 1, 2015
A predictive multi-linear regression model for organic micropollutants, based on a laboratory-scale column study simulating the river bank filtration processC Bertelkamp, A R D Verliefde, J Reynisson, et al.
Pageof 16